Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Counteracting muscle wasting in HIV-infected individuals Dudgeon WD; Phillips KD; Carson JA; Brewer RB; Durstine JL; Hand GAHIV Med 2006[Jul]; 7 (5): 299-310HIV-infected persons often experience a loss of lean tissue mass, which includes decreases in skeletal muscle mass. This HIV-associated wasting is significant because it has been associated with accelerated disease progression and increased morbidity. Signalling related to several circulating molecules, including tumour necrosis factor (TNF)-alpha, growth hormone, insulin-like growth factor (IGF)-1 and testosterone, has been associated with the aetiology of muscle wasting. Additionally, nutritional status related to malnutrition and specific dietary deficiencies may be involved. In an attempt to counter muscle wasting in HIV-infected persons, treatments have been suggested that target these mechanisms. Nutritional supplementation, cytokine reduction, hormone therapy and resistance exercise training are potential treatments for this condition. Resistance exercise training, which is more easily accessible to this population than other treatments, holds promise in counteracting the process of HIV wasting, as it has been successfully used to increase lean tissue mass in healthy and clinical populations. This review will explore the HIV/AIDS muscle-wasting syndrome, its aetiology, and the treatments used to counteract wasting.|*HIV Wasting Syndrome/etiology/therapy[MESH]|Cytokines/therapeutic use[MESH]|Exercise Therapy[MESH]|Growth Hormone/therapeutic use[MESH]|HIV Infections/*complications[MESH]|Hormone Replacement Therapy[MESH]|Humans[MESH]|Insulin-Like Growth Factor I/therapeutic use[MESH]|Malnutrition/diet therapy/etiology[MESH]|Muscular Atrophy/etiology/therapy[MESH]|Nandrolone Decanoate[MESH]|Nandrolone/analogs & derivatives/therapeutic use[MESH]|Testosterone/therapeutic use[MESH] |